Omacetaxine
Omacetaxine Mepesuccinate
Omacetaxine Mepesuccinate (pronounced as oh ma se tax' een me pe suk' i nate) is a chemotherapy drug used in the treatment of chronic myeloid leukemia (CML). It is also known by its brand name, Synribo.
Etymology
The name Omacetaxine Mepesuccinate is derived from its chemical structure. The term "Omacetaxine" is a combination of "Oma", which is short for homoharringtonine, the natural product from which it is derived, and "cetaxine", which is a suffix used in the naming of certain chemical compounds. "Mepesuccinate" refers to the salt form of the drug, which is a methyl ester of p-hydroxyphenylacetic acid.
Usage
Omacetaxine Mepesuccinate is used to treat chronic myeloid leukemia (CML) in adults who have not responded to other treatments or who cannot tolerate them. It works by slowing or stopping the growth of cancer cells.
Related Terms
Side Effects
Common side effects of Omacetaxine Mepesuccinate include diarrhea, nausea, fatigue, weakness, and injection site reactions. Serious side effects can include low blood cell counts, bleeding, and infections.
Precautions
Before starting treatment with Omacetaxine Mepesuccinate, patients should inform their healthcare provider about any other medications they are taking, as well as any medical conditions they have. It is also important to discuss the potential risks and benefits of treatment with this drug.
External links
- Medical encyclopedia article on Omacetaxine
- Wikipedia's article - Omacetaxine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski